| Answer | Antipsychotic | LA30297-8 |
| Answer | Antianxiety | LA30457-8 |
| Answer | Antidepressant | LA30458-6 |
| Answer | Hypnotic | LA30459-4 |
| Answer | Anticoagulant (e.g., warfarin, heparin, or low-molecular weight heparin) | LA30460-2 |
| Answer | Antibiotic | LA30299-4 |
| Answer | Diuretic | LA30461-0 |
| Answer | Opioid | LA28420-0 |
| Answer | Antiplatelet | LA30300-0 |
| Answer | Hypoglycemic (including insulin) | LA30301-8 |
| answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
| answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
| answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
| answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
| answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
| answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
| answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
| LONG_COMMON_NAME | en-US | High-risk drug classes - indication noted |
LOINC Version: 2.77
FHIR